Relationship of RASSFIA promoter methylation with expressions of Cyclin Dl and P53 in colorectal cancer

Chinese Journal of Cancer Biotherapy

Volumn 17, Issue 4, 2010, Pages 444-449

  Hu, Jia Le ^a   Chen, Yun ^a   Liu, Sheng ^a   Chen, Sen Lin ^a   Jiang, Meng Jie ^a  

^a No 411 Hospital of PLA   (China)

Author keywords

Colorectal neoplasms; Cyclin Dl; P53; Ras association domain family 1A gene (RASSFIA)

Indexed keywords

CYCLIN D1; PROTEIN P53; RAS ASSOCIATION DOMAIN FAMILY PROTEIN 1A;

ADULT; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GROUPS BY AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MALE; METHYLATION; POLYMERASE CHAIN REACTION; PROMOTER REGION;

EID: 77956893379     PISSN: 1007385X     EISSN: None     Source Type: Journal    
DOI: 10.3872/j.issn.1007-385X.2010.04.016     Document Type: Article

References (26)

1. Hesson LB, Cooper WN, Latif F. The role of RASSF1A methylation in cancer [J]. Disease Markers, 2007, 23(1/2): 73-87.
2. Greenspan EJ, Jablonski MA, Rajan TV, Levine J, Belinsky GS, Rosenberg DW. Epigenetic alterations in RASSF1A in human aberrant crypt foci [J]. Carcinogenesis, 2006, 27(7): 1316-1322.
3. Prabhu JS, Korlimarla A, Banerjee A, Wani S, Sahoo PK R. Gene-specific methylation: Potential markers for colorectal cancer [J]. Int J Biol Markers, 2009, 24(1): 57-62.
4. Noda H, Mashima R, Kamiyama H, Okada SY, Kawamura J, Konishi F. Promoter hypermethylation of tumor-related genes in sporadic colorectal cancer in young patients [J]. J Exp Clin Cancer Res, 2007, 26(4): 521-526. (Pubitemid 351157870)
5. Xu XL, Yu J, Zhang HY, Sun MH, Gu J, Du X, et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis [J]. World J Gastroenterol, 2004, 10(23): 3441-3454. (Pubitemid 39549544)
6. van der Weyden L, Adams DJ. The Ras-association domain family (RASSF) members and their role in human tumourigenesis [J]. Biochim Biophys Acta, 2007, 1776(1): 58-85.
7. Wagner KJ, Cooper WN, Grundy RG, Caldwell G, Jones C, Wadey RB, et al. Frequent RASSF1A tumour suppressor gene promoter methylation in Wilms ' tumour and colorectal cancer [J]. Oncogene, 2002, 21(47): 7277-7282.
8. van-Engeland M, MJM Roemen G, Brink M, Pachen MM, Weijenberg MP, de Bruïne AP, et al. K-ras mutations and RASSF1A promoter methylation in colorectal cancer [J]. Oncogene, 2002, 21(23): 3792-3795.
9. Ahlquist T, Bottillo I, Danielsen SA, Meling GI, Rognum TO, Lind GE, et al. Ras signaling in colorectal carcinomas through alteration of RAS, RAF, NF1, and/or RASSF1A [J]. Neoplasia, 2008, 10(7): 680-686.
10. Derks S, Postma C, Carvalho B, van den Bosch SM, Moerkerk PT, Herman JG, et al. Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations [J]. Carcinogenesis, 2008, 29(2): 434-439.
11. Pfeifer GP, Dammann R. Methylation of the tumor suppressor gene RASSF1A in human tumors [J]. Biochemistry (Mosc), 2005, 70 (5): 576-583.
12. Guo W, Dong Z, Chen Z, Yang Z, Wen, Kuang G, et al. Aberrant CpG island hypermethylation of RASSF1A in gastric cardia adenocarcinoma [J]. Cancer Invest, 2009, 27(4): 459-465.
13. Chen WC, Lin MS, Zhang BF, Fang J, Zhou Q, Hu Y, et al. Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray [J]. World J Gastroenterol, 2007, 13(5): 699-708. (Pubitemid 46252391)
14. Noda H, Kato Y, Yoshikawa H, Arai M, Togashi K, Nagai H, et al. Frequent involvement of Ras-signalling pathways in both polypoid-type and flat-type early-stage colorectal cancers [J]. J Exp Clin Cancer Res, 2006, 25(2): 235-242.
15. Kee SK, Lee JY, Kim MJ, Lee SM, Jung YW, Kim YJ, et al. Hypermethylation of the Ras association domain family 1A (RASSF1A) gene in gallbladder cancer [J]. Mol Cells, 2007, 24 (3): 364-371.
16. Pallares J, Velasco A, Eritja N, Santacana M, Dolcet X, Cuatrecasas M, et al. Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma [J]. Mod Pathol, 2008, 21(6): 691-699.
17. Derks S, Postma C, Moerkerk PT, van den Bosch SM, Carvalho B, Hermsen MA, et al. Promoter methylation precedes chromosomal alterations in colorectal cancer development [J]. Cell Oncol, 2006, 28(5/6): 247-257.
18. Sakamoto N, Terai T, Ajioka Y, Abe S, Kobayasi O, Hirai S, et al. Frequent hypermethylation of RASSF1A in early flat-type colorectal tumors [J]. Oncogene, 2004, 23(55): 8900-8907.
19. Peters I, Rehmet K, Wilke N, Kuczyk MA, Hennenlotter J, Eilers T, et al. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis [J]. Mol Cancer, 2007, 6: 49.
20. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. p53 in colorectal cancer: Clinicopathological correlation and prognostic significance [J]. Br J Cancer, 1991, 63(2): 317-319.